JFrog Ltd. heads into the final week of June with a familiar and unresolved tension: the Street is raising targets with unusual conviction, while the executives who built the company keep reducing their holdings at every opportunity.
The analyst move worth noting this week came from UBS, which raised its price target from $80 to $92 on June 24 while keeping a Buy rating — the latest in a string of upward revisions that now span six firms since early May. TD Cowen lifted to $100 on June 18, B of A Securities moved to $100 on June 8, and Barclays raised to $88 on June 10. Every recent change has been a raise, and every rating has stayed positive. The consensus mean target now sits at $83.75, above the current $78.71 close, implying modest upside even after a 6.4% gain over the past month. Bulls point to JFrog's AI-powered DevOps platform, strong infrastructure positioning, and 25% annual sales growth. Bears flag a crowded DevSecOps market, dependence on the US market, and an EV/EBITDA multiple of 66x that leaves little room for execution stumbles. Forward EPS estimates rank in the 85th percentile for year-over-year growth, which partially justifies the premium — but the PE of 80x is still demanding for a company whose earnings yield (EP) has been drifting lower over the past month.
The insider selling documented in last week's note has not stopped. Co-founder and CTO Yoav Landman sold roughly 45,000 shares across four transactions on June 12, netting around $3.5 million. That followed CEO Shlomi Ben Haim's $7.9 million of sales on June 8 and C-suite officer Tali Notman's $1 million exit on June 5. The 90-day net figure is technically positive at $42.6 million, but that reflects prior-period options activity. The recent directional flow — founders, the CEO, and senior executives all trimming at prices between $77 and $86 — remains unmistakably outward. Notably, co-founder Frederic Simon also trimmed his position, with a reported change of -305,504 shares. Against that, Vanguard and Whale Rock hold the two largest institutional positions above 5% and 4.9% respectively, with Wasatch Advisors adding over 2.7 million shares in the most recent reporting period — a meaningful counterweight from the long-only side.
Positioning data is not adding much heat to the setup. Short interest is a modest 3.6% of free float, up about 3% on the week but down 16% over the past month — bears have been covering, not adding. Availability is extremely loose at over 2,400% of short interest, meaning the lending pool is enormous relative to what's borrowed. Cost to borrow jumped 53% on the week to 0.53%, but remains trivially low in absolute terms. None of this suggests meaningful squeeze risk or aggressive short-side conviction. Options traders are leaning the same way: the put/call ratio has collapsed to 0.26, well below its 20-day average of 0.42 and close to a 52-week low of 0.19. That's a call-heavy, directionally bullish options book — not a market hedging for downside. The ORTEX short score sits at 34.8, comfortably in neutral territory, and has been range-bound all week.
Peers have had a rougher week. DDOG fell 5.4%, GTLB dropped 4.6%, and ESTC lost 5.3%. FROG's flat-to-slightly-positive week (+0.3%) represents genuine relative strength in a sector that was under pressure. The outlier on the upside was RBRK, up 6.4% — a reminder that security-adjacent software names can diverge sharply depending on news flow.
Next earnings are scheduled for August 4. The prior two prints both produced next-day moves above 21%, with five-day follow-through of 16–21%. The degree to which the current gap between analyst conviction and insider behavior narrows — or widens — before that date is the main thing to track.
See the live data behind this article on ORTEX.
Open FROG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
